BeiGene, Ltd. (ONC) Income Statement
ONC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsONC revenue and net income
Where ONC's revenue goes
2025Each bar shows an amount and its share of revenue. ONC kept 5.4% of revenue as net income.
ONC profit margins
ONC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +40.2% | +55.7% | +76.8% | +89.8% |
| Gross profit | +45.3% | +60.6% | +81.4% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ONC quarterly EPS vs estimates
BeiGene beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 5, 2026 (estimate $2.34).
ONC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.34B | $3.81B | $2.46B | $1.42B | $1.18B | $308.9M | $428.2M | $198.2M | $238.4M | $1.1M |
| Cost of revenue | $668.5M | $594.1M | $379.9M | $286.5M | $164.9M | $70.7M | $71.2M | $707.7M | $274.0M | $98.0M |
| Gross profit | $4.67B | $3.22B | $2.08B | $1.13B | $1.01B | $238.2M | $357.0M | −$509.5M | −$35.6M | −$97.0M |
| Research & development | $2.15B | $1.95B | $1.78B | $1.64B | $1.46B | $1.29B | $927.3M | $679.0M | $269.0M | $98.0M |
| Sales, general & admin | $2.08B | $1.83B | $1.51B | $1.28B | $990.1M | $600.2M | — | $195.4M | $62.6M | $20.1M |
| Total operating expenses | $4.23B | $3.78B | $3.29B | $2.92B | $2.45B | $1.90B | $1.32B | $196.3M | $62.9M | $20.1M |
| Operating income | $447.1M | −$568.2M | −$1.21B | −$1.79B | −$1.44B | −$1.66B | −$959.9M | −$705.8M | −$98.5M | −$117.1M |
| Interest income | $70.5M | $47.8M | $74.0M | $52.5M | — | $2.0M | — | — | — | — |
| Interest expense | $58.2M | $21.8M | $4.4M | $52.5M | — | — | — | $13.9M | $4.1M | $383,000 |
| Income before taxes | $416.9M | −$533.0M | −$825.8M | −$1.96B | −$1.44B | −$1.62B | −$943.6M | −$689.8M | −$91.1M | −$119.2M |
| Income taxes | $129.9M | $111.8M | $55.9M | $42.8M | $19.2M | $10.4M | $7.0M | −$15.8M | $2.2M | $54,000 |
| Net income | $286.9M | −$644.8M | −$881.7M | −$2.00B | −$1.46B | −$1.62B | −$948.6M | −$673.8M | −$93.1M | −$119.2M |
| EBITDA | $616.8M | −$361.2M | −$738.2M | −$1.89B | −$1.39B | −$1.63B | −$941.3M | −$695.4M | −$93.7M | −$115.2M |
| EPS (diluted) | $2.52 | −$6.14 | −$8.45 | −$19.48 | −$15.16 | −$19.02 | −$15.74 | −$12.00 | −$1.92 | −$3.41 |
| Gross margin | 87.5% | 84.4% | 84.5% | 79.8% | 86.0% | 77.1% | 83.4% | −257.0% | −14.9% | −9,062.0% |
| Operating margin | 8.4% | −14.9% | −49.1% | −126.4% | −122.3% | −536.7% | −224.2% | −356.1% | −41.3% | −10,940.2% |
| Net margin | 5.4% | −16.9% | −35.9% | −141.5% | −123.9% | −526.1% | −221.5% | −339.9% | −39.1% | −11,141.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.51B | $1.50B | $1.41B | $1.32B | $1.12B | $1.13B | $1.00B | $929.2M | $751.7M | $634.4M | $781.3M |
| Cost of revenue | $174.5M | $167.2M | $142.4M | $196.5M | $164.6M | $165.0M | $160.6M | $170.5M | $138.1M | $124.9M | $105.8M | $96.3M |
| Gross profit | $1.53B | $1.35B | $1.36B | $1.22B | $1.15B | $952.3M | $967.3M | $831.1M | $791.0M | $626.7M | $528.6M | $685.0M |
| Research & development | $612.3M | $541.2M | $615.4M | $523.7M | $524.9M | $481.9M | $542.0M | $496.2M | $454.5M | $460.6M | $494.0M | $453.3M |
| Sales, general & admin | $593.2M | $555.1M | $555.3M | $529.0M | $537.9M | $459.3M | $504.7M | $455.2M | $443.7M | $427.4M | $416.5M | $365.7M |
| Total operating expenses | $1.21B | $1.10B | $1.17B | $1.05B | $1.06B | $941.2M | $1.05B | $951.4M | $898.2M | $888.1M | $912.4M | $819.0M |
| Operating income | $325.0M | $249.9M | $185.0M | $163.1M | $87.9M | $11.1M | −$79.4M | −$120.3M | −$107.2M | −$261.3M | −$383.8M | −$134.0M |
| Interest income | $27.9M | $27.7M | $58.1M | $3.0M | $3.5M | $5.8M | $7.8M | $10.6M | $13.2M | $16.2M | — | $26.6M |
| Interest expense | $39.7M | $32.9M | $58.2M | — | $8.0M | $7.0M | — | — | — | — | — | — |
| Income before taxes | $312.5M | $259.2M | $149.2M | $147.2M | $99.5M | $20.9M | −$85.4M | −$98.3M | −$105.9M | −$243.4M | −$350.8M | $229.3M |
| Income taxes | $75.5M | $31.9M | $82.7M | $22.3M | $5.2M | $19.6M | $66.5M | $23.0M | $14.5M | $7.7M | $16.8M | $13.9M |
| Net income | $237.0M | $227.4M | $66.5M | $124.8M | $94.3M | $1.3M | −$151.9M | −$121.3M | −$120.4M | −$251.2M | −$367.6M | $215.4M |
| EBITDA | $392.7M | $333.2M | $249.0M | $184.4M | $135.2M | $60.7M | −$35.1M | −$27.0M | −$81.8M | −$218.1M | −$327.0M | $250.8M |
| EPS (diluted) | $2.05 | $1.96 | $0.58 | $1.09 | $0.84 | $0.01 | −$1.43 | −$1.15 | −$1.15 | −$2.41 | −$3.48 | $2.01 |
| Gross margin | 89.8% | 89.0% | 90.5% | 86.1% | 87.5% | 85.2% | 85.8% | 83.0% | 85.1% | 83.4% | 83.3% | 87.7% |
| Operating margin | 19.1% | 16.5% | 12.4% | 11.5% | 6.7% | 1.0% | −7.0% | −12.0% | −11.5% | −34.8% | −60.5% | −17.1% |
| Net margin | 13.9% | 15.0% | 4.4% | 8.8% | 7.2% | 0.1% | −13.5% | −12.1% | −13.0% | −33.4% | −57.9% | 27.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ONC's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ONC financial results
In fiscal year 2025 (ended December 31, 2025), BeiGene reported revenue of $5.3 billion, up 40.2% from the year before. It had net income of $286.9 million, a net profit margin of 5.4%. Diluted earnings per share came to $2.52. Over five years revenue grew at an average rate of 76.8% a year.
See the ONC stock overview for the latest quote and news, or the ONC chart for price history and technical indicators.
ONC income statement FAQ
What is BeiGene's annual revenue?
BeiGene reported total revenue of $5.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 40.2% from $3.8 billion the previous year.
Is BeiGene profitable?
Yes. BeiGene reported net income of $286.9 million in fiscal 2025, a net profit margin of 5.4%; its operating margin was 8.4%.
What is BeiGene's gross margin?
BeiGene's gross margin was 87.5% in fiscal 2025: for every $100 of revenue, BeiGene kept $87 after the direct cost of its products and services.
How much does BeiGene spend on research and development?
BeiGene spent $2.1 billion on research and development in fiscal 2025, 40.2% of revenue.
How fast is BeiGene growing?
Revenue grew 76.8% a year on average over the last five fiscal years, from $308.9 million to $5.3 billion.
What are BeiGene's earnings per share?
BeiGene earned $2.52 per diluted share in fiscal 2025, compared with $-6.14 a year earlier.
When will BeiGene report its next earnings?
BeiGene is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does BeiGene's fiscal year end?
BeiGene's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.